Gustaf Ahlén

1.6k total citations
38 papers, 1.0k citations indexed

About

Gustaf Ahlén is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Gustaf Ahlén has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 19 papers in Epidemiology and 9 papers in Molecular Biology. Recurrent topics in Gustaf Ahlén's work include Hepatitis C virus research (22 papers), Hepatitis B Virus Studies (19 papers) and Immunotherapy and Immune Responses (5 papers). Gustaf Ahlén is often cited by papers focused on Hepatitis C virus research (22 papers), Hepatitis B Virus Studies (19 papers) and Immunotherapy and Immune Responses (5 papers). Gustaf Ahlén collaborates with scholars based in Sweden, Germany and United States. Gustaf Ahlén's co-authors include Matti Sällberg, Lars Frelin, Ola Weiland, Anette Braß, M. Fóns, Magnus Johansson, Marianne van Hage, Thi Anh Thu Tran, Iacob Mathiesen and Carl Hamsten and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Gustaf Ahlén

38 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gustaf Ahlén Sweden 18 342 332 280 248 237 38 1.0k
Anne Louise France 21 756 2.2× 370 1.1× 637 2.3× 145 0.6× 381 1.6× 33 2.0k
Danushka K. Wijesundara Australia 16 252 0.7× 133 0.4× 344 1.2× 184 0.7× 195 0.8× 39 741
Denise M. McKinney United States 25 687 2.0× 429 1.3× 1.1k 3.9× 490 2.0× 899 3.8× 32 2.2k
Kay Townsend United States 16 298 0.9× 82 0.2× 502 1.8× 230 0.9× 452 1.9× 22 1.2k
Uma Kavita United States 16 528 1.5× 54 0.2× 736 2.6× 175 0.7× 375 1.6× 19 1.3k
Charles Buscarino United States 12 150 0.4× 83 0.3× 161 0.6× 474 1.9× 222 0.9× 15 1.0k
Urs Hoffmann Rohrer Switzerland 9 324 0.9× 73 0.2× 993 3.5× 214 0.9× 343 1.4× 9 1.5k
H. Baumgarten Germany 9 636 1.9× 391 1.2× 202 0.7× 144 0.6× 284 1.2× 12 944
Marie‐France del Guercio United States 18 354 1.0× 82 0.2× 1.3k 4.7× 174 0.7× 904 3.8× 21 1.9k
Dace Skrastiņa Latvia 19 422 1.2× 203 0.6× 246 0.9× 298 1.2× 301 1.3× 45 1.0k

Countries citing papers authored by Gustaf Ahlén

Since Specialization
Citations

This map shows the geographic impact of Gustaf Ahlén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gustaf Ahlén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gustaf Ahlén more than expected).

Fields of papers citing papers by Gustaf Ahlén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gustaf Ahlén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gustaf Ahlén. The network helps show where Gustaf Ahlén may publish in the future.

Co-authorship network of co-authors of Gustaf Ahlén

This figure shows the co-authorship network connecting the top 25 collaborators of Gustaf Ahlén. A scholar is included among the top collaborators of Gustaf Ahlén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gustaf Ahlén. Gustaf Ahlén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahlén, Gustaf, Sandra Ciesek, Anna Pasetto, et al.. (2022). Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections. Gut. 72(6). 1186–1195. 7 indexed citations
2.
Appelberg, Sofia, Gustaf Ahlén, Olivia Larsson, et al.. (2022). A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells. EMBO Molecular Medicine. 14(10). e15821–e15821. 14 indexed citations
3.
Hawman, David W., Kimberly Meade‐White, Shanna Leventhal, et al.. (2022). Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model. Molecular Therapy. 31(2). 387–397. 22 indexed citations
4.
Hawman, David W., Gustaf Ahlén, Kimberly Meade‐White, et al.. (2020). A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model. Nature Microbiology. 6(2). 187–195. 59 indexed citations
5.
Varnaitė, Renata, Marina García, Hedvig Glans, et al.. (2020). Expansion of SARS-CoV-2–Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients. The Journal of Immunology. 205(9). 2437–2446. 56 indexed citations
6.
Hagner-McWhirter, Åsa, et al.. (2019). A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk Product. Genetic Engineering & Biotechnology News. 39(5). 62–64. 2 indexed citations
7.
Ahlén, Gustaf, et al.. (2016). A targeted controlled force injection of genetic material in vivo. Molecular Therapy — Methods & Clinical Development. 3. 16016–16016. 8 indexed citations
8.
Sällberg, Matti, et al.. (2016). A non-human hepadnaviral adjuvant for hepatitis C virus-based genetic vaccines. Vaccine. 34(25). 2821–2833. 9 indexed citations
9.
Ahlén, Gustaf, et al.. (2014). Long-term functional duration of immune responses to HCV NS3/4A induced by DNA vaccination. Gene Therapy. 21(8). 739–750. 13 indexed citations
10.
Sällberg, Matti, Lars Frelin, Gustaf Ahlén, & Margaret Chen. (2014). Electroporation for therapeutic DNA vaccination in patients. Medical Microbiology and Immunology. 204(1). 131–135. 22 indexed citations
11.
Braß, Anette, Lars Frelin, David R. Milich, Matti Sällberg, & Gustaf Ahlén. (2014). Functional Aspects of Intrahepatic Hepatitis B Virus-specific T Cells Induced by Therapeutic DNA Vaccination. Molecular Therapy. 23(3). 578–590. 10 indexed citations
12.
Ahlén, Gustaf, Lars Frelin, Erwin Daniel Brenndörfer, et al.. (2013). Containing “The Great Houdini” of viruses: Combining direct acting antivirals with the host immune response for the treatment of chronic hepatitis C. Drug Resistance Updates. 16(3-5). 60–67. 10 indexed citations
13.
Weiland, Ola, Gustaf Ahlén, Helmut M. Diepolder, et al.. (2013). Therapeutic DNA Vaccination Using In Vivo Electroporation Followed by Standard of Care Therapy in Patients With Genotype 1 Chronic Hepatitis C. Molecular Therapy. 21(9). 1796–1805. 62 indexed citations
14.
Fournillier, Anne, Lars Frelin, Gustaf Ahlén, et al.. (2013). A Heterologous Prime/Boost Vaccination Strategy Enhances the Immunogenicity of Therapeutic Vaccines for Hepatitis C Virus. The Journal of Infectious Diseases. 208(6). 1008–1019. 45 indexed citations
15.
Ahlén, Gustaf, et al.. (2012). Mannosylated Mucin-Type Immunoglobulin Fusion Proteins Enhance Antigen-Specific Antibody and T Lymphocyte Responses. PLoS ONE. 7(10). e46959–e46959. 22 indexed citations
16.
Nyström, Jessica, Antony Chen, Lars Frelin, et al.. (2010). Improving on the Ability of Endogenous Hepatitis B Core Antigen to Prime Cytotoxic T Lymphocytes. The Journal of Infectious Diseases. 201(12). 1867–1879. 17 indexed citations
17.
Frelin, Lars, Anette Braß, Gustaf Ahlén, et al.. (2010). Electroporation: A promising method for the nonviral delivery of DNA vaccines in humans?. Drug News & Perspectives. 23(10). 647–647. 14 indexed citations
18.
Ahlén, Gustaf, Malin Weiland, Jian Jiao, et al.. (2008). Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes. Gut. 58(4). 560–569. 28 indexed citations
19.
Ahlén, Gustaf, Jonas Söderholm, Torunn Elisabeth Tjelle, et al.. (2007). In Vivo Electroporation Enhances the Immunogenicity of Hepatitis C Virus Nonstructural 3/4A DNA by Increased Local DNA Uptake, Protein Expression, Inflammation, and Infiltration of CD3+ T Cells. The Journal of Immunology. 179(7). 4741–4753. 108 indexed citations
20.
Frelin, Lars, Gustaf Ahlén, Mats Alheim, et al.. (2004). Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene. Gene Therapy. 11(6). 522–533. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Louise Breakdown of academic impact, for papers by Danushka K. Wijesundara Breakdown of academic impact, for papers by Denise M. McKinney Breakdown of academic impact, for papers by Kay Townsend Breakdown of academic impact, for papers by Uma Kavita Breakdown of academic impact, for papers by Charles Buscarino Breakdown of academic impact, for papers by Urs Hoffmann Rohrer Breakdown of academic impact, for papers by H. Baumgarten Breakdown of academic impact, for papers by Marie‐France del Guercio Breakdown of academic impact, for papers by Dace Skrastiņa
Rankless by CCL
2026